Clinical Trials Sponsored by Hubei Cancer Hospital

Total 10087 results

Seattle Children's Hospital
Fred Hutchinson Cancer Center

Completed

Improving Physical Activity in Young Adult Cancer Survivors

Quality of Life | Physical Activity

United States
Incheon St.Mary's Hospital
National Cancer Center, Korea

Unknown

Procarbazine and Lomustine in Recurrent Glioblastoma

Recurrent Glioblastoma Multiforme

Korea, Republic of
University Hospital Heidelberg
German Cancer Research Center

Unknown

Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer (NEOPANC)

Pancreatic Neoplasms

Germany
Fujian Cancer Hospital
Hunan Cancer Hospital; Wuhan TongJi Hospital

Not yet recruiting

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Small Cell Lung Cancer

China
Hebei Yanda Ludaopei Hospital
China Immunotech (Beijing) Biotechnology Co., Ltd.; Avalon GloboCare Corp.

Completed

CD19-CAR-T in B-cell Malignancies Patients

B-cell Malignancy

China
Massachusetts General Hospital
M.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Dana-Farber...

Completed

Detecting EGFR T790M Mutations From Circulating Tumor Cells

Non Small Cell Lung Cancer

United States
Korea Cancer Center Hospital
Asan Medical Center; Seoul National University Hospital; Gangnam Severance Hospital

Recruiting

Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer (TACO)

Cervical Cancer

Korea, Republic of, China, Thailand, Vietnam
Peking University People's Hospital
Xijing Hospital; Beijing Friendship Hospital; Peking Union Medical College Hospital and other collaborators

Recruiting

Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial (EXPLORE)

Rectal Cancer | Pathological Complete Response | Disease Free Survival

China
Institute of Medical Biology, Chinese Academy of...
Hubei Provincial Center for Disease Control and Prevention

Completed

The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

Hand, Foot and Mouth Disease (HFMD)

China
Institute of Medical Biology, Chinese Academy of...
Hubei Provincial Center for Disease Control and Prevention

Active, not recruiting

Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Epidemic Parotitis,Mumps

China
Peking Union Medical College Hospital
The Second Hospital of Hebei Medical University; Zhongda Hospital; Second Affiliated... and other collaborators

Recruiting

Clinical and Basic Researches Related to ZhenQi Buxue Oral Liquid in Treating Menstrual Disorders

Menstrual Disorders

China
Saitama Medical University International Medical...
National Cancer Center, Japan; Tokyo University; Cancer Institute Hospital, Japan and other collaborators

Active, not recruiting

Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer

Cervical Cancer

Japan
Ding Ke-Feng
The First Affiliated Hospital with Nanjing Medical University; Zhejiang Cancer... and other collaborators

Recruiting

the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium

Colorectal Cancer

China
Peking Union Medical College Hospital
Peking University People's Hospital; Chinese PLA General Hospital; Tongji Hospital and other collaborators

Recruiting

Withdraw Drug in Stable IgG4-Related Disease

Autoimmune Diseases

China
Massachusetts General Hospital
M.D. Anderson Cancer Center; National Cancer Institute (NCI)

Active, not recruiting

High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull

Chordoma of Sacrum | Chordoma of Spine | Chordoma of Base of Skull | Chondrosarcoma of the Spine | Chondrosarcoma of the Sacrum

United States
Barretos Cancer Hospital
University of Campinas, Brazil; AC Camargo Cancer Center

Unknown

Metformin Plus Irinotecan for Refractory Colorectal Cancer

Adenocarcinoma | Colorectal Neoplasms

Brazil
German Cancer Research Center
University Hospital Heidelberg; University Hospital Dresden

Not yet recruiting

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients With AML (GALAXY33)

Relapsed/Refractory Acute Myeloid Leukemia (AML)

Germany
Huazhong University of Science and Technology
Maternal and Child Health Hospital of Hubei Province; Wuhan Central Hospital; Wuhan Maternal and Child Health Hospital

Unknown

Tongji Maternal and Child Health Cohort (TMCHC)

Pregnancy Complications | Breast Feeding | Weight Gain | Diet Habit | Growth and Development | Birth Outcomes | Maternal; Diabetes Mellitus, Affecting Fetus
Changhai Hospital
The Second Hospital of Hebei Medical University; Qilu Hospital of Shandong... and other collaborators

Completed

A Study on a Blood-based Dual-target Test for CRC Detection

Colorectal Cancer | Colorectal Adenoma

China
Huazhong University of Science and Technology
Fudan University; Second Affiliated Hospital of Zhengzhou University; Renmin... and other collaborators

Unknown

The Relationship Between Psychological Factors and Bell's Palsy

Bell's Palsy

China
University Hospital Heidelberg
German Cancer Research Center; University Hospital Dresden

Active, not recruiting

OPPOSITE: Outcome Prediction Of Systemic Treatment in Esophagogastric Carcinoma (OPPOSITE)

Esophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm

Germany
University Hospital Heidelberg
German Cancer Research Center; University Hospital Dresden

Terminated

Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival (PERDAM)

Leukemia, Myeloid, Acute

Germany
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Adelphi University; Queen's Hospital Center

Completed

Measurement of Cancer-Related Risk Perception in Smokers

Survey | Risk Perception | Cancer Related-Risks | Focus Group

United States
Huazhong University of Science and Technology
Fudan University; Second Affiliated Hospital of Zhengzhou University; Renmin... and other collaborators

Completed

Acupuncture With Deqi And Psychological Effects in Treatment of Bell's Palsy (ADAPT)

Bell's Palsy

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Massachusetts General Hospital

Active, not recruiting

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

Esophageal Cancer

United States
Massachusetts General Hospital
M.D. Anderson Cancer Center; National Cancer Institute (NCI)

Active, not recruiting

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma

Brain Tumor | Medulloblastoma | Pineoblastoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Massachusetts General Hospital

Completed

Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer

United States
West China Hospital
Zhejiang Cancer Hospital; Hebei General Hospital; Beijing Tongren Hospital; The... and other collaborators

Unknown

Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans

Hyperthyroidism | Tomography | Emission-Computed | Single-Photon

China
Institute of Medical Biology, Chinese Academy of...
Hubei Provincial Center for Disease Control and Prevention

Active, not recruiting

Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11

Epidemic Parotitis, Mumps

China
Henan Cancer Hospital

Not yet recruiting

Serplulimab Plus Chemotherapy for Early-stage ER+/HER2- Breast Cancer

Breast Cancer

China
Zhejiang Cancer Hospital

Recruiting

Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer

Non-Resectable Pancreas Carcinoma

China
Zhejiang Cancer Hospital

Recruiting

Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma

HER2 Gene Mutation | Bile Duct Adenocarcinoma Non-Resectable

China
Zhejiang Cancer Hospital

Not yet recruiting

Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital

Recruiting

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Gastric Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Biliary Tract Cancer | Gastroesophageal Junction Adenocarcinoma | Liver Cancer Stage IV

China
Henan Cancer Hospital

Recruiting

Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer

Metastatic Gastroesophageal Junction Adenocarcinoma

China
Fujian Cancer Hospital

Not yet recruiting

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Metastatic Nasopharyngeal Carcinoma | Intermittent Systematic Chemotherapy
Henan Cancer Hospital

Not yet recruiting

Tace With Icaritin in First-line Treatment of Middle and Advanced HCC in Child Grade B Patients

HCC
Henan Cancer Hospital

Not yet recruiting

Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

Breast Cancer | HER2-positive Breast Cancer

China
Henan Cancer Hospital

Not yet recruiting

A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer (SCLC)

SCLC,Extensive Stage
Henan Cancer Hospital

Not yet recruiting

Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression

Gastric Cancer

China
Zhejiang Cancer Hospital

Recruiting

The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity (START)

Cardiotoxicity Induced by Drug Therapy for Breast Cancer

China
Fujian Cancer Hospital

Not yet recruiting

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

EGFR Positive Non-small Cell Lung Cancer

China
Zhejiang Cancer Hospital

Recruiting

Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation

Liver Cancer | Ciprofol

China
Henan Cancer Hospital

Recruiting

The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)

Non-hodgkin Lymphoma,B Cell

China
Fujian Cancer Hospital

Not yet recruiting

Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life

Nasopharyngeal Carcinoma

China
Fujian Cancer Hospital

Recruiting

Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer

Untreated Advanced Non-small Cell Lung Cancer

China
Fujian Cancer Hospital

Not yet recruiting

New-mode Clinical Target Volume Delineation of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma by AJCC V8 Stage
Fujian Cancer Hospital

Not yet recruiting

PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors

Advanced Solid Tumor
Zhejiang Cancer Hospital

Not yet recruiting

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Non-small Cell Lung Cancer Stage III
Zhejiang Cancer Hospital

Recruiting

3D Printed Models for Liver Surgery

Liver Cancer

China

Clinical Trials Sponsored by Hubei Cancer Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations